Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Arkadiusz Rudawski, PhDCracow University of TechnologyArkadiusz Rudawski, PhD posted this:
Technology Broker at Cracow University of Technology
Laser Consult Ltd. posted this:
Multifunctional Syringe (Protected Healthcare Workers)This is a medical device, is a syringe, which solves the problem of the danger of infecting patients and health care workers with diseases that can be transmitted by injecting with an already used needle. With this new syringe model, you can apply the drug enormously quickly while protecting yourself. It is intended for a single use with only one use practically possible. The dosage is much easier because it has two measuring scales. The volume is 15ml but can be changed as needed is it can be produced in different sizes. The disinfection mechanism is in the syringe, and one of the novelties is that the needle has no contact with the healthcare worker applying the therapy.
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
COVID-19 Rapid Diagnostic KitDesigning and developing vaccines, cures and diagnostic kits can be considered as the first priority for every country which is in the first line of fighting against coronavirus. Now there is only PCR test and IgG/IgM test for COVID-19 assessment. One of the most important problems of this diagnostic test is the time needed by the device to detect infected persons. This problem makes big companies in the field of pharmaceutical and medical devices manufacturing to design and develop rapid test kits. Our research team found that there are some specific proteins on the viral membrane which can make some reagents undergo a specific chemical reaction. Every reaction has a specific product related to substrates, so by detection of products with indicator reagents we are able to identify the virus in saliva. Indicator reagents usually change the reaction mixture color so by color change we can approve that the person is infected by COVID-19.
Alireza DaneshvarTehran University of Medical SciencesPharmacy Student and Researcher at Tehran University of Medical Sciences
View ProfileAlireza Daneshvar posted this:
Pharmacy Student and Researcher at Tehran University of Medical Sciences
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Expertise in molecular biology either experimentally or computationallyThe Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.
IBB-UAB posted this:
Expertise in molecular biology either experimentally or computationallyThe Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: • Bioinformatics • Cellular Biology • Structural Biology • Genomics • Immunology • Microbiology • Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.
TEC Edmonton posted this:
Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion InhibitorsA series of small pharmacological molecules have been discovered to be potent and non-cytotoxic inhibitors of viral fusion. The inhibitors act on the non-virally encoded lipids in the virion envelope. These molecules are rigid amphipathic compounds of inverted cone shape which locate to the outer leaflets of virion envelopes, creating a physical barrier to viral envelope and cell membrane fusion. These amphipathic nucleoside derivatives can serve as potential antiviral or therapeutic agents against herpes, HIV, influenza, hepatitis B & C, poxvirus and other DNA or RNA enveloped viruses. They can potentially be used as prophylactic ingredients in creams, lotions, gels and as antiviral disinfectants.
Pascal Mayer posted this:
CEO at Alphanosos
Pascal Mayer posted this:
CEO at Alphanosos
Centre Technology Transfer CITTRUCentre Technology Transfer CITTRUCentre Technology Transfer CITTRU posted this:
A NEW DRUG FOR THE PREVENTION AND TREATMENT OF FELINE HERPESVIRUS TYPE 1 (FHV-1) AND FELINE CALICIVIRUS (FCV) INFECTIONSThe subject of the proposed offer is a new innovation of the Jagiellonian University - a new potential drug - poly(sodium 4-styrenesulfonates), (PSSNa), which can be used for treatment of FHV-1 and FCV infections.
Ivan Rodriguez RoselloUniversidad de AlicanteIvan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
